CLINICAL_TRIALS trial_result · 2009-12-18

Clinical Trial Update: A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus [Phase 3]

Phase 3 study evaluating the safety of rituximab retreatment in systemic lupus erythematosus was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Genentech, Inc. | Conditions: Lupus Erythematosus, Systemic | Phase 3 | Status: TERMINATED | Results posted: 2009-12-18